The connection between GRKs and various signaling pathways involved in diabetic nephropathy

Molecular Biology Reports

Volumn 39, Issue 7, 2012, Pages 7717-7726

  Wang, Feng Ling ^a   Tang, Li Qin ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; G protein coupled; G protein coupled receptor kinases; Receptors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E; PROSTAGLANDIN E2; PROTEIN KINASE C; RUBOXISTAURIN; TRANSFORMING GROWTH FACTOR BETA;

ADD ON THERAPY; ARTICLE; CAUSE OF DEATH; DIABETIC NEPHROPATHY; DIABETIC PATIENT; HUMAN; MICROANGIOPATHY; MOLECULAR RECOGNITION; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

DIABETIC NEPHROPATHIES; G-PROTEIN-COUPLED RECEPTOR KINASES; HUMANS; PROTEIN KINASE C; RECEPTORS, PROSTAGLANDIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864280362     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1608-x     Document Type: Article

References (87)

1. Kanwar YS, Sun L, Xie P, Liu FY, Chen S (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol Mech 6:395-423
2. Schena FP, Gesualdo L (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16:S30-S33 (Pubitemid 41725079)
3. Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27:195-207 (Pubitemid 46550314)
4. Wolf G, Ziyadeh FN (2007) Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 106:26-31
5. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373 (Pubitemid 36519197)
6. Premont RT, Gainetdinov RR (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69:511-534 (Pubitemid 46457653)
7. Penela P, Murga C, Ribas C, Lafarga V, Mayor F Jr (2010) The complex G protein-coupled receptor kinase 2 (GRK2) interac-tome unveils new physiopathological targets. Br J Pharmacol 160:821-832
8. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510
9. Ribas C, Penela P, Murga C, Salcedo Al, García-Hoz C, Jurado-Pueyo M, Aymerich I, MayorF (2007) The G protein-coupled receptor kinase (GRK) interactome: Role of GRKsin GPCR regulation and signaling. BBA-Biomembranes 1768(4):913-922 (Pubitemid 46452540)
10. Garcia-Higuera I, Penela P, Murga C, Egea G, Bonay P, Benovic JL, Mayor F Jr (1994) Association of the regulatory beta-adren-ergic receptor kinase with rat liver microsomal membranes. J Biol Chem 269:1348-1355
11. Murga C, Ruiz-Gomez A, Garcia-Higuera I, Kim CM, Benovic JL, Mayor F Jr (1996) High affinity binding of beta-adrenergic receptor kinase to microsomal membranes. Modulation of the activity of bound kinase by heterotrimeric G protein activation. J Biol Chem 271:985-994
12. Ribas Catalina, Penela Petronila (2007) The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768:913-922
13. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ (1992) Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 257:1264-1267
14. Koch WJ, Inglese J, Stone WC, Lefkowitz RJ (1993) The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J Biol Chem 268:8256-8260 (Pubitemid 23120415)
15. Touhara K, Koch WJ, Hawes BE, Lefkowitz RJ (1995) Muta-tional analysis of the pleckstrin homology domain of the beta-adrenergic receptor kinase. Differential effects on G beta gamma and phosphatidylinositol 4, 5-bisphosphate binding. J Biol Chem 270:17000-17005
16. Pitcher JA, Freedman NJ, Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67:653-692 (Pubitemid 28411141)
17. Premont RT, Macrae AD, Aparicio SA, Kendall HE, Welch JE, Lefkowitz RJ (1999) The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation. J Biol Chem 274:29381-29389
18. Vatter P, Stoesser C, Samel I, Gierschik P, Moepps B (2005) The variable C-terminal extension of G-protein-coupled receptor kinase 6 constitutes an accessorial autoregulatory domain. FEBS J 272:6039-6051 (Pubitemid 41715234)
19. Pronin AN, Carman CV, Benovic JL (1998) Structure-function analysis of G protein-coupled receptor kinase-5. Role of the carboxyl terminus in kinase regulation. J Biol Chem 273:31510-31518 (Pubitemid 28533173)
20. Uriuhara A, Miyata S, Liu BF et al (2008) Methylglyoxal induces prostaglandin E2 production in rat mesangial cells. Kobe J Med Sci 53(6):305-315
21. Negishi M, Sugimoto Y, Ichikawa A (1995) Prostaglandin E receptors. J Lipid Mediat Cell Signal 12:379-391
22. Coleman RA, Smith WL, Narumiya S (1994) International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229 (Pubitemid 24185151)
23. Negishi M, Sugimoto Y, Irie A, Narumiya S, Ichikawa A (1993) Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J Biol Chem 268:9517-9521 (Pubitemid 23146006)
24. Nishigaki N, Negishi M, Ichikawa A (1996) Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol Pharmacol 50:1031-1037 (Pubitemid 26347726)
25. Bastepe M, Ashby B (1997) The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization. Mol Pharmacol 51:343-349 (Pubitemid 27074157)
26. Premont RT, Inglese J, Lefkowitz RJ (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 9:175-182
27. Breyer MD, Linda D, Jacobson HR, Breyer RM (1996) Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol 270:F912-F918
28. Breyer MD, Davis L, Jacobson HR, Breyer RM (1996) Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol Renal Physiol 270:F912-F918
29. Breyer MD, Breyer RM (2000) Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 279:F12-F23 (Pubitemid 30619543)
30. Makino H, Tanaka I, Mukoyama M, Sugawara A, Mori K, Muro S, Suganami T, Yahata K, Ishibashi R, Ohuchida S, Maruyama T, Narumiya S, Nakao K (2002) Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. J Am Soc Nephrol 13:1757-1765 (Pubitemid 34700600)
31. Akita type I diabetic mice. Am J Physiol Renal Physiol 292(1):F278
32. Noh H, King GL (2007) The role of PKC activation in diabetic nephropathy. Kidney Int 106:S49-S53 (Pubitemid 47172561)
33. Parker PJ, Murray-Rust J (2004) PKC at a glance. J Cell Sci 117:131-132 (Pubitemid 38128893)
34. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY et al (2007) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through PKC-a-dependent pathway. Diabetes 57:460-469
35. Geraldes P, King GL (2010) Activation of protein kinase C iso-forms and its impact on diabetic complications. Circ Res 106(8):1319-1331
36. Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW (2005) The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 28:2686-2690 (Pubitemid 43951160)
37. Yang XL, Zhang YL, Lai ZS, Xing FY, Liu YH (2003) Pleckstrin homology domain of G protein-coupled receptor kinase-2 binds to PKC and affects the activity of PKC kinase. World J Gastro-enterol 9(4):800-803
38. Ji S, Liu X, Li S, Shen L, Li F, Wang J, Han J, Yao L (2003) PH domain of G protein-coupled receptor kinase-2 binds to protein kinase C (PKC) and negatively regulates activity of PKC kinase. Front Biosci 8:a34-a39 (Pubitemid 39069941)
39. Price D, De'Oliveira J, Fisher N et al (1999) The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type 2 diabetes mellitus. Am J Hypertens 12:348
40. Ho J, Cocolakis E, Dumas VM, Posner BL, Laporte SA, Lebrun JJ (2005) The G protein-coupled receptor kinase-2 is TGFb inducible antagonist of TGFb signal transduction. EMBO J 24:3247-3258 (Pubitemid 41348699)
41. Djordjevic VB (2004) Free radicals in cell biology. Int Rev Cytol 237:57-89 (Pubitemid 39221038)
42. Banday AA, Lokhandwala MF (2007) Oxidative stress reduces renal dopamine D1 receptor-Gq/11a G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2. Am J Physiol Renal Physiol 293:F306-F315 (Pubitemid 47345031)
43. Aperia AC (2000) Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62:621-647 (Pubitemid 30618277)
44. Hussain T, Lokhandwala MF (1998) Renal dopamine receptor function in hypertension. Hypertension 32:187-197 (Pubitemid 28376472)
45. Banday AA, Marwaha A, Tallam LS, Lokhandwala MF (2005) Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G protein coupling and function in obese Zucker rats. Diabetes 54:2219-2226 (Pubitemid 40911287)
46. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S (2001) Mechanism of sodium load-induced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res 24:127-135 (Pubitemid 32377583)
47. Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR (2006) The D1 dopamine receptor is constitutively phos-phorylated by G protein coupled receptor kinase 4. Mol Pharmacol 69:759-769 (Pubitemid 43363850)
48. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD et al (2002) G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99(6):3872-3877 (Pubitemid 34252198)
49. Trivedi M, Lokhandwala MF (2005) Rosiglitazone restores renal d1a receptor-gs protein coupling by reducing receptor hyper-phosphorylation in obese rats. Am J Physiol Renal Physiol 289:F298-F304 (Pubitemid 41003659)
50. Asghar M, Banday AA, Fardoun RZ, Lokhandwala MF (2006) Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic Biol Med 40:13-20 (Pubitemid 41759399)
51. Sterne-Marr R, Tesmer JJ, Day PW, Stracquatanio RP, Cilente JA, O'Connor KE, Pronin AN, Benovic JL, Wedegaertner PB (2003) G protein coupled receptor kinase 2/Gaq/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits. J Biol Chem 278:6050-6058 (Pubitemid 36800856)
52. Reeves WB, Andreoli TE (2000) Transforming growth factor b contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 97:7667-7669 (Pubitemid 30460701)
53. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700 (Pubitemid 36724933)
54. Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for TGF-b as the major mediator. J Am Soc Nephrol 15:S55-S57 (Pubitemid 38018457)
55. Leask A, Abraham DJ (2004) TGF-b signaling and the fibrotic response. FASEB J 18:816-827
56. Shi Y, Massague J (2003) Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113(6):685-700 (Pubitemid 36724933)
57. Guinti S, Barit D, Cooper ME (2006) Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 48:519-526 (Pubitemid 44843845)
58. Epstein M, Sowers J (1992) Diabetes mellitus and hypertension. Hypertension 19:403-418
59. Jandeleit-Dahm K, Cooper ME (2006) Hypertension and diabetes: role of renin-angiotensin system. Endocrino Meab Clin N Am 35:469-490 (Pubitemid 44321946)
60. Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59:251-287 (Pubitemid 47481436)
61. Navar LG, Arendshorst WJ, Pallone TL, Inscho EW, Imig JD, Bell PD (2008) The renal microcirculation. In: Tuma RF, Duran WN, Ley K (eds) Handbook of physiology: microcirculation. Academic Press, San Diego, pp 550-683
62. Navar LG, Kobori H, Prieto-Carrasquero MC (2003) Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 5:135-143 (Pubitemid 38898943)
63. Navar LG (2005) The role of the kidneys in hypertension. J Clin Hypertens (Greenwich) 7:542-549
64. Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB (2006) Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Front Biosci 11:968-976 (Pubitemid 43253451)
65. Siragy HM, Awad A, Abadir P, Webb R (2003) The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-a in diabetic rats. Endocrinology 144:2229-2233 (Pubitemid 36629871)
66. Singh R, Alavi N, Singh AK, Leehey DJ (1999) Role of angio-tensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48:2066-2073 (Pubitemid 29458373)
67. Singh R, Singh AK, Leehey DJ (2005) A novel mechanism for angiotensin II formation in streptozotocin diabetic rat glomeruli. Am J Physiol 288:F1183-F1190 (Pubitemid 40677088)
68. Oppermann M, Freedman NJ, Alexander RW, Lefkowitz RJ (1996) Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem 271:13266-13272
69. Jose PA, Soares-da-Silva P, Gilbert ME, Felder RA (2010) Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 1802:1259-1267
70. Donatelli M, Colletti I, Bucalo M et al (1994) Plasma endothelin levels in NIDDM patients with macroangiopathy. Diabetes Res 25:159-164
71. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ (1997) Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G proteincoupled receptor kinase specificity. J Biol Chem 272:17734-17743 (Pubitemid 27311212)
72. Usui I, Imamura T, Satoh H, Huang J, Babendure JL, Hupfeld CJ, Olefsky JM (2004) GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J 23:2821-2829 (Pubitemid 39013554)
73. Maruyama I, Bell CE, Majerus PW (1985) Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 101:363-371 (Pubitemid 15239110)
74. Iwashima Y, Sato T, Watanabe K et al (1990) Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39:983-988 (Pubitemid 20233733)
75. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068 (Pubitemid 121001193)
76. Ishii K, Chen J, Ishii M, Koch WJ, Freedman NJ, Lefkowitz RJ, Coughlin SR (1994) Inhibition of thrombin receptor signaling by a g-protein coupled receptor kinase. J Biol Chem 269:1125-1130
77. Davidson MB, Bate G, Kirkpatrick P (2005) Exenatide. Nat Rev Drug Discov 4:713-714
78. MacDonald PE, El Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB (2002) The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51(3):S434-S442 (Pubitemid 35403427)
79. Jorgensen R, Martini L, Schwartz TW, Elling CE (2005) Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype. Mol Endocrinol 19:812-823 (Pubitemid 40349451)
80. Jorgensen R, Kubale V, Vrecl M (2007) Oxyntomodulin differentially affects glucagon-like peptide-1 receptor -beta-arrestin recruitment and signaling through GaS. J Pharmacol Exp Ther 322:148-154
81. Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, Jurado-Pueyo M, Zalba G, Díez J, Murga C, Fernández-Veledo S, Mayor F Jr, Lorenzo M (2010) G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 59(10):2407-2417
82. Trivedi M, Lokhandwala MF (2005) Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyper-phosphorylation in obese rats. Am J Physiol Renal Physiol 289:F298-F304 (Pubitemid 41003659)
83. Mayor F Jr, Lucas E, Jurado-Pueyo M, Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, Fernández-Veledo S, Murga C (2011) G Protein-coupled receptor kinase 2 (GRK2): a novel modulator of insulin resistance. Arch Physiol Biochem 117(3):125-130
84. Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H, Yokoyama H (2005) Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis 45:54-65 (Pubitemid 40038045)
85. Tian W, Zhang Z, Cohen DM (2000) MAPK signaling and the kidney. Am J Physiol Renal Physiol 279:F593-F604
86. Herlaar E, Brown Z (1999) p38MAPK signaling cascades in inflammatory disease. Mol Med Today 5:439-447 (Pubitemid 29455026)
87. Jurado-Pueyo M, Campos PM, Mayor F, Murga C (2008) GRK2-dependent desensitization downstream of G proteins. J Recept Signal Transduct Res 28:59-70 (Pubitemid 351588075)